These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 29761239)
1. Kinetics and Characterization of Non-enzymatic Fragmentation of Monoclonal Antibody Therapeutics. Ravuluri S; Bansal R; Chhabra N; Rathore AS Pharm Res; 2018 May; 35(7):142. PubMed ID: 29761239 [TBL] [Abstract][Full Text] [Related]
2. Discovery and characterization of CHO host cell protease-induced fragmentation of a recombinant monoclonal antibody during production process development. Yang B; Li W; Zhao H; Wang A; Lei Y; Xie Q; Xiong S J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Apr; 1112():1-10. PubMed ID: 30836312 [TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of monoclonal antibody fragments cleaved at the complementarity determining region using orthogonal analytical methods. Li W; Yang B; Zhou D; Xu J; Li W; Suen WC J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Mar; 1048():121-129. PubMed ID: 28242491 [TBL] [Abstract][Full Text] [Related]
4. Investigating the Degradation Behaviors of a Therapeutic Monoclonal Antibody Associated with pH and Buffer Species. Zheng S; Qiu D; Adams M; Li J; Mantri RV; Gandhi R AAPS PharmSciTech; 2017 Jan; 18(1):42-48. PubMed ID: 26340951 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of the impact of antibody fragments on aggregation of intact molecules via size exclusion chromatography coupled with native mass spectrometry. Xu J; Coughlin JE; Szyjka M; Jabary S; Saluja S; Sosic Z; Chen Y; Xu CF MAbs; 2024; 16(1):2334783. PubMed ID: 38536719 [TBL] [Abstract][Full Text] [Related]
6. Non-enzymatic hinge region fragmentation of antibodies in solution. Cordoba AJ; Shyong BJ; Breen D; Harris RJ J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Apr; 818(2):115-21. PubMed ID: 15734150 [TBL] [Abstract][Full Text] [Related]
7. Comparison of SEC and CE-SDS methods for monitoring hinge fragmentation in IgG1 monoclonal antibodies. Dada OO; Rao R; Jones N; Jaya N; Salas-Solano O J Pharm Biomed Anal; 2017 Oct; 145():91-97. PubMed ID: 28654781 [TBL] [Abstract][Full Text] [Related]
8. Impact of various factors on the kinetics of non-enzymatic fragmentation of a monoclonal antibody. Gupta S; Upadhyay K; Schöneich C; Rathore AS Eur J Pharm Biopharm; 2022 Sep; 178():131-139. PubMed ID: 35961566 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of automated Wes system as an analytical and characterization tool to support monoclonal antibody drug product development. Wang J; Valdez A; Chen Y J Pharm Biomed Anal; 2017 May; 139():263-268. PubMed ID: 28069351 [TBL] [Abstract][Full Text] [Related]
11. Hyphenation of size exclusion chromatography to native ion mobility mass spectrometry for the analytical characterization of therapeutic antibodies and related products. Ehkirch A; Hernandez-Alba O; Colas O; Beck A; Guillarme D; Cianférani S J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Jun; 1086():176-183. PubMed ID: 29684909 [TBL] [Abstract][Full Text] [Related]
12. The relative rate of immunoglobulin gamma 1 fragmentation. Kamerzell TJ; Li M; Arora S; Ji JA; Wang YJ J Pharm Sci; 2011 Apr; 100(4):1341-9. PubMed ID: 24081469 [TBL] [Abstract][Full Text] [Related]
13. Size-exclusion chromatography-mass spectrometry with m-nitrobenzyl alcohol as post-column additive for direct characterization of size variants of monoclonal antibodies. Xu CF; Zang L; Weiskopf A J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Jun; 960():230-8. PubMed ID: 24835510 [TBL] [Abstract][Full Text] [Related]
14. Understanding the Increased Aggregation Propensity of a Light-Exposed IgG1 Monoclonal Antibody Using Hydrogen Exchange Mass Spectrometry, Biophysical Characterization, and Structural Analysis. Bommana R; Chai Q; Schöneich C; Weiss WF; Majumdar R J Pharm Sci; 2018 Jun; 107(6):1498-1511. PubMed ID: 29408480 [TBL] [Abstract][Full Text] [Related]
15. Analytical Platform for Monitoring Aggregation of Monoclonal Antibody Therapeutics. Bansal R; Gupta S; Rathore AS Pharm Res; 2019 Aug; 36(11):152. PubMed ID: 31463609 [TBL] [Abstract][Full Text] [Related]
16. Fragmentation of a Monoclonal Antibody by Peroxotungstate. Rathnayaka H; Mozziconacci O; Sreedhara A; Schöneich C Pharm Res; 2018 Sep; 35(11):219. PubMed ID: 30255209 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of a non-Arrhenius model for therapeutic monoclonal antibody aggregation. Kayser V; Chennamsetty N; Voynov V; Helk B; Forrer K; Trout BL J Pharm Sci; 2011 Jul; 100(7):2526-42. PubMed ID: 21268027 [TBL] [Abstract][Full Text] [Related]
18. Fragmentation of a recombinant monoclonal antibody at various pH. Gaza-Bulseco G; Liu H Pharm Res; 2008 Aug; 25(8):1881-90. PubMed ID: 18473123 [TBL] [Abstract][Full Text] [Related]
19. Therapeutic protein purity and fragmented species characterization by capillary electrophoresis sodium dodecyl sulfate using systematic hybrid cleavage and forced degradation. Duhamel L; Gu Y; Barnett G; Tao Y; Voronov S; Ding J; Mussa N; Li ZJ Anal Bioanal Chem; 2019 Aug; 411(21):5617-5629. PubMed ID: 31214752 [TBL] [Abstract][Full Text] [Related]
20. Characterization of a recombinant humanized anti-cocaine monoclonal antibody and its Fab fragment. Kirley TL; Norman AB Hum Vaccin Immunother; 2015; 11(2):458-67. PubMed ID: 25692880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]